# Montreux Growth Partners: portfolio, investments and team > Montreux Growth Partners is a vc firm based in United States. 45 investments on record, 1 in the last 12 months, latest Jan 2026. Source: https://millionrounds.com/fund/montreux-growth-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Montreux Growth Partners Last cheque observed Jan 2026; 45 cheques on record. Email Deploying now New fund $74M, Aug 2015 VC firm Seed Series A Series B Mental Health Digital-health Health-tech Follow Montreux Growth Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fmontreux-growth-partners) Deploying now **100%** of best year **1** **cheques in 12 months**, 45 on record Since the last cheque **292** days **00** hrs **00** min **00** sec Median round **$250M** Rounds led **0 of 45** Sole investor **2 rounds** Exits **6 from the portfolio** Mostly in **United States, 95%** Pitch Montreux Growth Partners ## Montreux Growth Partners highlights - 01 1 cheques in the last 12 months - 02 Mostly Series B and Series A: 48% of its rounds - 03 Sole investor in 2 rounds, median $16M - 04 6 exits from the portfolio ## What they do > Montreux invests in high growth, commercial stage companies with category leading products, technologies, and services. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Mental Health Digital-health Health-tech - **Based in:** San Francisco, United States - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **45 appearances** - **2026** 1 round - **Jan** **[Tebra](https://millionrounds.com/company/tebra)** Growth · US · TechStartups **$250M** With 6 others - **2015** 1 round - **Jul** **[Kareo](https://millionrounds.com/company/kareo)** Series G · US **$55M** With 7 others - **2014** 5 rounds - **May** **[Pure life renal](https://millionrounds.com/company/pure-life-renal)** Series A · US **$20M** With 2 others - **Apr** **[SI-BONE](https://millionrounds.com/company/si-bone)** Venture · US **$33M** With 3 others - **Apr** **[Epirus Biopharmaceuticals](https://millionrounds.com/company/epirus-biopharmaceuticals)** Series B · US **$36M** With 7 others - **Feb** **[GC Aesthetics](https://millionrounds.com/company/gc-aesthetics)** Growth · IE **$60M** With 2 others - **Feb** **[MINDBODY](https://millionrounds.com/company/mindbody)** Growth · US **$50M** With 4 others - **2013** 2 rounds - **Jun** **[Colorescience](https://millionrounds.com/company/colorescience)** Series A · US · pevc.dowjones.com **$10M** With 1 other - **Feb** **[Glaukos](https://millionrounds.com/company/glaukos)** Series F · US · pevc.dowjones.com **$30M** With 6 others - **2012** 3 rounds - **Jul** **[Epirus Biopharmaceuticals](https://millionrounds.com/company/epirus-biopharmaceuticals)** Venture · US **$5.0M** With 1 other - **Apr** **[Epirus Biopharmaceuticals](https://millionrounds.com/company/epirus-biopharmaceuticals)** Venture · US **$8.1M** With 1 other - **Jan** **[Pulmonx](https://millionrounds.com/company/pulmonx)** Growth · US · researchviews.com **$10M** With 4 others - **2011** 3 rounds - **Nov** **[Pivot Medical](https://millionrounds.com/company/pivot-medical)** Series C · US · finsmes.com **$32M** With 3 others - **Sept** **[SI-BONE](https://millionrounds.com/company/si-bone)** Venture · US · finsmes.com **$16M** With 1 other - **Feb** **[Glaukos](https://millionrounds.com/company/glaukos)** Series E · US · fis.dowjones.com **$30M** With 6 others - **2010** 4 rounds - **Oct** **[GC Aesthetics](https://millionrounds.com/company/gc-aesthetics)** Venture · IE · gcaesthetics.com **$30M** Sole investor - **Sept** **[Tobira Therapeutics](https://millionrounds.com/company/tobira-therapeutics)** Series B · US · tobiratherapeutics.com **$31M** With 4 others - **Jun** **[Avantis Medical Systems](https://millionrounds.com/company/avantis-medical-systems)** Debt · US · sec.gov **$2.8M** Sole investor - **Mar** **[Pulmonx](https://millionrounds.com/company/pulmonx)** Series C · US · onbiovc.com **$32M** With 6 others - **2008** 1 round - **Aug** **[Glaukos](https://millionrounds.com/company/glaukos)** Series D · US · equityhelpdesk.com **$35M** With 6 others - **2007** 6 rounds - **Nov** **[Novalar Pharmaceuticals](https://millionrounds.com/company/novalar-pharmaceuticals)** Series D · US **$30M** With 2 others - **Sept** **[Sequel Pharmaceuticals](https://millionrounds.com/company/sequel-pharmaceuticals)** Series A · US **$20M** With 4 others - **Aug** **[KFx Medical](https://millionrounds.com/company/kfx-medical)** Series B · US **$10M** With 4 others - **Aug** **[Tobira Therapeutics](https://millionrounds.com/company/tobira-therapeutics)** Series A · US **$31M** With 3 others - **May** **[Pulmonx](https://millionrounds.com/company/pulmonx)** Series B · US · venturebeat.com **$20M** With 3 others - **Mar** **[Transcept Pharmaceuticals](https://millionrounds.com/company/transcept-pharmaceuticals)** Series D · US · deals.venturebeat.com **$40M** With 7 others - **2006** 2 rounds - **Nov** **[Avantis Medical Systems](https://millionrounds.com/company/avantis-medical-systems)** Series B · US · deals.venturebeat.com **$12M** With 1 other - **Sept** **[NovaCardia](https://millionrounds.com/company/novacardia)** Series B · US **$48M** With 5 others - **2005** 4 rounds - **Dec** **[NeurogesX](https://millionrounds.com/company/neurogesx)** Series D · US **$20M** With 5 others - **Aug** **[KFx Medical](https://millionrounds.com/company/kfx-medical)** Series A · US **$6.2M** With 3 others - **Jun** **[Verus Pharmaceuticals](https://millionrounds.com/company/verus-pharmaceuticals)** Series A · US **$78M** With 6 others - **Apr** **[SkinMedica](https://millionrounds.com/company/skinmedica)** Series E · US **$15M** With 6 others - **2004** 5 rounds - **Aug** **[Avera Pharmaceutical](https://millionrounds.com/company/avera-pharmaceutical)** Series C · US **$48M** With 10 others - **Jul** **[SkinMedica](https://millionrounds.com/company/skinmedica)** Series D · US **$30M** With 5 others - **Jun** **[Somaxon Pharmaceuticals](https://millionrounds.com/company/somaxon-pharmaceuticals)** Series B · US **$23M** With 5 others - **Jun** **[ARYx Therapeutics](https://millionrounds.com/company/aryx-therapeutics)** Series D · US **$55M** With 9 others - **Jan** **[Peninsula Pharmaceuticals](https://millionrounds.com/company/peninsula-pharmaceuticals)** Series C · US **$58M** With 5 others - **2003** 1 round - **Sept** **[Marketwired](https://millionrounds.com/company/marketwired)** Series D · US **$4.6M** With 8 others - **2002** 3 rounds - **Oct** **[Peninsula Pharmaceuticals](https://millionrounds.com/company/peninsula-pharmaceuticals)** Series B · US **$22M** With 5 others - **Mar** **[Internet Wire](https://millionrounds.com/company/internet-wire)** Venture **$4.0M** With 4 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **3 named** DK **Daniel K. Turner** Managing Member of the Manager i Filing they signed HD **Howard D. Palefsky** Managing Member of the Manager i Filing they signed JJ **John J. Savarese** Managing Member of the Manager i Filing they signed We also hold **9** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What they claim to have backed From their own portfolio page (on their website) **0** of 1 we have independently watched raise FINE Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **6 in all** **[Pivot Medical](https://millionrounds.com/company/pivot-medical)** Bought by Stryker Corporation **Undisclosed** Jan 2014 **[Somaxon Pharmaceuticals](https://millionrounds.com/company/somaxon-pharmaceuticals)** Bought by Pernix Therapeutics **Undisclosed** Mar 2013 **[SkinMedica](https://millionrounds.com/company/skinmedica)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **Undisclosed** Nov 2012 **[NovaCardia](https://millionrounds.com/company/novacardia)** Bought by Merck & Co. **$366M** Sept 2007 **[NeurogesX](https://millionrounds.com/company/neurogesx)** Listed **Undisclosed** Feb 2007 **[Peninsula Pharmaceuticals](https://millionrounds.com/company/peninsula-pharmaceuticals)** Bought by [Johnson & Johnson](https://millionrounds.com/fund/johnson-and-johnson) **Undisclosed** Apr 2005 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$74M** raised in Aug 2015 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$250M** the round, not its cheque Alone, median **$16M** Led 0 of 45 rounds **0%** - **Sole investor:** 2 rounds - **Last cheque:** Jan 2026 - **Exits:** 6 from the portfolio Rounds by stage said on their site - Series B said *10* - Series A said *9* - Series D *7* - Venture *6* - Series C *4* - Growth said *4* - Seed said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Domain Associates](https://millionrounds.com/fund/domain-associates) 14 - [OrbiMed](https://millionrounds.com/fund/orbimed) 7 - [Frazier Healthcare Partners](https://millionrounds.com/fund/frazier-healthcare-partners) 6 - [Hummer Winblad Venture Partners](https://millionrounds.com/fund/hummer-winblad-venture-partners) 6 - [InterWest Partners](https://millionrounds.com/fund/interwest-partners) 6 - [Osprey Ventures](https://millionrounds.com/fund/osprey-ventures) 6 **Pitching Montreux Growth Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Montreux Growth Partners. A count of rooms they were both in, not a relationship either has claimed. [**Domain Associates** VC firm **14** rounds together](https://millionrounds.com/fund/domain-associates)[**OrbiMed** Private equity **7** rounds together](https://millionrounds.com/fund/orbimed)[**Frazier Healthcare Partners** Private equity **6** rounds together](https://millionrounds.com/fund/frazier-healthcare-partners)[**Hummer Winblad Venture Partners** VC firm **6** rounds together](https://millionrounds.com/fund/hummer-winblad-venture-partners)[**InterWest Partners** VC firm **6** rounds together](https://millionrounds.com/fund/interwest-partners)[**Osprey Ventures** VC firm **6** rounds together](https://millionrounds.com/fund/osprey-ventures)[**Sequoia Capital** VC firm **6** rounds together](https://millionrounds.com/fund/sequoia-capital)[**Canaan** VC firm **4** rounds together](https://millionrounds.com/fund/canaan-partners)[**Mindfull Investors** VC firm **4** rounds together](https://millionrounds.com/fund/mindfull-investors)[**Perkins Coie** Corporate VC **4** rounds together](https://millionrounds.com/fund/perkins-coie)[**Skyline Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/skyline-ventures)[**Stanford University** VC firm **4** rounds together](https://millionrounds.com/fund/ahpcrc) ## Recently backed The latest companies Montreux Growth Partners put money into. [**Tebra** $250M · Jan 2026](https://millionrounds.com/company/tebra) ## Quick answers about Montreux Growth Partners ### What does Montreux Growth Partners invest in? Montreux Growth Partners invests most often at Series B and Series A (48% of the rounds on record), in sectors such as Mental Health, Digital-health and Health-tech. ### How active is Montreux Growth Partners? 45 investments on record, 1 of them in the last 12 months. The most recent was in Jan 2026. ### What has Montreux Growth Partners invested in recently? Its most recent investments on record: Tebra (Growth, Jan 2026). ### How big are Montreux Growth Partners's cheques? The median round it joins is $250M. ### Does Montreux Growth Partners lead rounds? Rarely, if at all: none of its 45 investments on record names it as the lead. ### Where does Montreux Growth Partners invest? Most of the companies it backs are in the United States (95%) and Ireland (5%). ### Is Montreux Growth Partners investing now? Yes: it is actively investing, with 1 investments in the last 12 months. ### Who does Montreux Growth Partners invest alongside? Most often Domain Associates (14 rounds together), OrbiMed (7 rounds together) and Frazier Healthcare Partners (6 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=montreux-growth-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=montreux-growth-partners)